http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101055576-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2007-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101055576-B1 |
| titleOfInvention | Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| abstract | The present invention relates to novel compounds of formula (I) having 11β-HSD type 1 antagonist activity and also to methods of preparing such compounds. In another embodiment, the present invention provides a pharmaceutical composition comprising a compound of formula (I), and also for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and other conditions associated with 11β-HSD type 1 activity. To methods of using the compounds and compositions for the same.n n n <Formula I>n n n n n n n n Cyclohexylpyrazole-lactam derivatives, 11-beta-hydroxysteroid dehydrogenase 1, diabetes mellitus, metabolic syndrome |
| priorityDate | 2006-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.